← back to search

Marta Filizola

Icahn School of Medicine at Mount Sinai · US
Area of research
Molecular Biology · Cellular and Molecular Neuroscience
Research interest
Research interests include Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Cell Adhesion Molecules Research, and Computational Drug Discovery Methods.
h-index
49
citations
9,457
works
269
NIH funding
primary concept
email

Recent publications

Synthesis and Characterization of Photoswitchable Covalent Ligands for the β <sub>2</sub> ‐Adrenoceptor
Angewandte Chemie International Edition 2025cited by 3position: middledoi
Synthesis and Characterization of Photoswitchable Covalent Ligands for the β <sub>2</sub> ‐Adrenoceptor
Angewandte Chemie 2025cited by 0position: middledoi
Structural basis of positive allosteric modulation of metabotropic glutamate receptor activation and internalization
Nature Communications 2024cited by 15position: middledoi
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects
Journal of Medicinal Chemistry 2021cited by 74position: middledoi
GPCRmd uncovers the dynamics of the 3D-GPCRome
Nature Methods 2020cited by 194position: middledoi
Promoting transparency and reproducibility in enhanced molecular simulations
Nature Methods 2019cited by 1,270position: middledoi
Structural basis of TRPV5 channel inhibition by econazole revealed by cryo-EM
Nature Structural & Molecular Biology 2017cited by 134position: middledoi
Synthetic and Receptor Signaling Explorations of the <i>Mitragyna</i> Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators
Journal of the American Chemical Society 2016cited by 313position: middledoi
Membrane Driven Spatial Organization of GPCRs
Scientific Reports 2013cited by 118position: middledoi
Inward-facing conformation of the zinc transporter YiiP revealed by cryoelectron microscopy
Proceedings of the National Academy of Sciences 2013cited by 111position: middledoi
Membrane Curvature Regulates the Oligomerization of Human β2-Adrenergic Receptors
Biophysical Journal 2013cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Davide Provasi · Icahn School of Medicine at Mount Sinai5 papers (2013–2025)Dalibor Sameš · Columbia University2 papers (2016–2021)Dorothée Weikert · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2025–2025)Ulrike Wirth · University of Regensburg2 papers (2025–2025)Kevin W. Huynh · Pfizer (United States)2 papers (2017–2024)Eduard Neu · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2025–2025)Maximilian F. Schmidt · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2025–2025)Abhijeet Kapoor · National Institutes of Health2 papers (2016–2017)Jonathan A. Javitch · Columbia University Irving Medical Center2 papers (2016–2021)Peter Gmeiner · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2025–2025) · 2 papers (2016–2021)Harald Hübner · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2025–2025)Burkhard König · University of Regensburg2 papers (2025–2025)Tibor Rohács · Rutgers, The State University of New Jersey1 papers (2017–2017)Elyssa B. Margolis · University of California, San Francisco1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Bryan L. Roth · University of North Carolina at Chapel Hill1 papers (2021–2021)Sudha Chakrapani · Case Western Reserve University1 papers (2017–2017)Dagan C. Marx · Cornell University1 papers (2024–2024)